Expertise in
4
conditions

Dr. Coy D. Heldermon

Oncology
UF Health Center For Pediatric Neuromuscular And Rare Diseases
1549 Gale Lemerand Dr Fl Second, 
Gainesville, FL 
Accepting New Patients
Offers Telehealth
Expertise in
4
conditions
UF Health Center For Pediatric Neuromuscular And Rare Diseases
1549 Gale Lemerand Dr Fl Second, 
Gainesville, FL 

Overview

Coy Heldermon is an Oncologist practicing medicine in Gainesville, Florida.

Dr. Heldermon is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Angiosarcoma, Paget Disease of the Breast, Inflammatory Breast Cancer, and Tissue Biopsy.

He is actively involved in clinical research, co-authoring 57 peer reviewed articles and participating in 5 clinical trials. Dr. Heldermon is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in MO

Hospital Affiliations

Uf Health Shands Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

UF Health Center for Pediatric Neuromuscular and Rare Diseases
1549 Gale Lemerand Dr Fl Second, Gainesville, FL 32610

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase I/II, Multicenter, Open-Label, Single-Dose, Dose-Ranging Study to Assess the Safety and Tolerability of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy, in Subjects With Fabry Disease (STAAR)
A Phase I/II, Multicenter, Open-Label, Single-Dose, Dose-Ranging Study to Assess the Safety and Tolerability of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy, in Subjects With Fabry Disease (STAAR)
Enrollment Status: Completed
Publish Date: April 14, 2026
Intervention Type: Biological
Study Drug: ST-920
Study Phase: Phase 1/Phase 2
Early Markers of Subclinical Pulmonary Vascular Radiation Toxicity in Breast Cancer
Early Markers of Subclinical Pulmonary Vascular Radiation Toxicity in Breast Cancer
Enrollment Status: Completed
Publish Date: August 22, 2024
Intervention Type: Procedure, Radiation
A Randomized, Double Blind, Active Control Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function in Patients With Fabry Disease Previously Treated With Agalsidase Beta
A Randomized, Double Blind, Active Control Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function in Patients With Fabry Disease Previously Treated With Agalsidase Beta
Enrollment Status: Completed
Publish Date: September 13, 2023
Intervention Type: Biological
Study Drugs: PRX-102 (Pegunigalsidase Alfa), Agalsidase Beta
Study Phase: Phase 3
A Phase I / 2, Multicenter, Open-label, Single-dose, Dose-ranging Study to Assess the Safety and Tolerability of SB-318, a rAAV2/6-based Gene Transfer in Subjects With Mucopolysaccharidosis I (MPS I)
A Phase I / 2, Multicenter, Open-label, Single-dose, Dose-ranging Study to Assess the Safety and Tolerability of SB-318, a rAAV2/6-based Gene Transfer in Subjects With Mucopolysaccharidosis I (MPS I)
Enrollment Status: Terminated
Publish Date: January 26, 2023
Intervention Type: Biological
Study Drug: SB-318
Study Phase: Phase 1/Phase 2
Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients
Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients
Enrollment Status: Withdrawn
Publish Date: January 13, 2020
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 4 Less Clinical Trials

57 Total Publications

Retraction: A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells.
Retraction: A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells.
Journal: The Biochemical journal
Published: June 03, 2026
Similar Doctors
Expertise in
18
conditions
Expertise in
18
conditions
Referral may be required

Uf Health Urology-Medical Plaza

1549 Gale Lemerand Dr Fl 3, 
Gainesville, FL 
 (0.1 miles away)
352-265-8240
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Paul Crispen is an Oncologist practicing medicine in Gainesville, Florida. Dr. Crispen is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Crispen is currently accepting new patients.

Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required

Uf Health Medical Lab-Shands Hospital

1600 SW Archer Rd, 
Gainesville, FL 
 (1.3 miles away)
352-265-0725
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Frederic Kaye is an Oncologist practicing medicine in Gainesville, Florida. Dr. Kaye is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC). Dr. Kaye is currently accepting new patients.

Expertise in
7
conditions
Expertise in
7
conditions
Referral may be required

UF Health Bone Marrow Transplant

1515 SW Archer Rd Ste 100, 
Gainesville, FL 
 (1.4 miles away)
352-733-0972
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Christopher Cogle is an Oncologist practicing medicine in Gainesville, Florida. Dr. Cogle is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Leukemia, Multiple Myeloma, and Bone Marrow Aspiration. Dr. Cogle is currently accepting new patients.

Frequently Asked Questions about Dr. Coy D. Heldermon

How do I make an appointment with Dr. Coy D. Heldermon?

You can book an appointment with Dr. Coy D. Heldermon by calling their office at 877-543-7783. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Coy D. Heldermon a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Coy D. Heldermon is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Coy D. Heldermon specialize in?

While Dr. Coy D. Heldermon is a Oncology, they have specific expertise in Breast Cancer, Angiosarcoma, and Paget Disease of the Breast. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Coy D. Heldermon participate in research or clinical trials?

Yes. Dr. Coy D. Heldermon has published 57 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Coy D. Heldermon's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Coy D. Heldermon accept my insurance?

Dr. Coy D. Heldermon accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 877-543-7783 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Heldermon's expertise for a condition
ConditionClose
    View All 24 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile